Documents Ravi Vij MD Associate Professor Section of BMT and Leukemia

Management of Older Patients Not Eligible For Transplant Induction Therapy For Multiple Myeloma: Two vs Three Drug Regimen and Role of Risk Stratification Ravi Vij MD Associate…

Documents Long-Term Ixazomib Maintenance Is Tolerable and Improves Depth of Response Following...

Research To Practice Long-Term Ixazomib Maintenance Is Tolerable and Improves Depth of Response Following Ixazomib-Lenalidomide-Dexamethasone Induction in Patients with Previously…

Documents Ravi Vij MD Associate Professor Section of BMT and Leukemia

Management of Older Patients Not Eligible For Transplant Induction Therapy For Multiple Myeloma: Two vs Three Drug Regimen and Role of Risk Stratification Ravi Vij MD Associate…

Documents Copyright © 2010, Research To Practice, All rights reserved. Part III: Multiple Myeloma Monday,...

Kenneth C Anderson, MD Kraft Family Professor of Medicine, Harvard Medical School Chief, Division of Hematologic Neoplasia Director, Jerome Lipper Multiple Myeloma Center…